Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeResource RepositoryHumanized TFRC and CD98hc mouse models for BBB and AAV brain delivery
Poster

Humanized TFRC and CD98hc mouse models for BBB and AAV brain delivery

An integrated BBB shuttle development workflow combining humanized TFRC and CD98hc mouse models with the HUGO-Nano™ fully human VHH discovery platform, demonstrating receptor-dependent antibody brain delivery in vivo and identifying anti-hTfR1 and anti-CD98hc nanobody candidates for CNS delivery of antibodies and AAV.
Humanized TFRC and CD98hc mouse models for BBB and AAV brain delivery

Overview

Delivering biologics to the CNS remains limited by the blood–brain barrier, with receptor-mediated transcytosis via TfR1 (TFRC) and CD98hc the leading strategy. We generated huTFRC, hTFRC(CDS), and huCD98HC(SLC3A2) mice, confirming human target expression at mRNA and protein level with colocalization to mCD31+ brain microvascular endothelium. Functionally, a TfR bispecific antibody showed significantly higher cerebral cortex accumulation and reduced plasma exposure at 24 h, while a CD98hc Shuttle achieved faster plasma clearance and significantly greater brain and parenchymal exposure peaking at Day 7. The HUGO-Nano™ platform yielded fully human VHHs binding native receptors at non-blocking epitopes with efficient endothelial internalization.

Key Insights

Validated humanized TFRC and CD98hc mouse models, paired with a fully human VHH discovery platform, form an integrated engine for developing and testing BBB shuttles for antibody and AAV brain delivery.
  • Faithfully humanized BBB receptor models. huTFRC, hTFRC(CDS), and huCD98HC(SLC3A2) mice express the human target in place of the mouse ortholog across brain and peripheral tissues, with confirmed colocalization to the mCD31+ brain microvascular endothelium.
  • Functional, receptor-dependent brain delivery demonstrated. A TfR bispecific antibody conjugate accumulated significantly more in the cerebral cortex than unconjugated protein at 24 h with reduced plasma levels, and a CD98hc Shuttle showed higher brain and parenchymal exposure than control IgG, peaking at Day 7.
  • Fully human nanobody shuttles from HUGO-Nano™. The repertoire showed 97.8% full-length and 96.0% CDR3 sequence uniqueness, yielding anti-hTfR1 VHHs with benchmark-equivalent binding at a non-blocking, non-transferrin-competing epitope and anti-CD98hc VHHs with low-nanomolar affinity and efficient hCMEC/D3 internalization.
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Download Details
Full Name
Email
Organization
Job Role
Country
Main Area of Research
Resource Preferences
Which type of solutions are you considering?
Do you plan to start a project with us within the next 6 months?
How did you hear about us?
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research